Follow the 株式会社ステムリム stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares are listed on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社ステムリム has published 6 reports. Market capitalisation: €21.9bn. The latest transaction was filed on 27 August 2026 (Holding update). Among the most active insiders: Tomita Kensuke. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
株式会社ステムリム is a Japanese company operating in the healthcare and pharmaceutical sector. It is listed on the XTKS market.